News

1 to 9 of 81 results

Valeant to serve as “stalking horse bidder” in court-supervised Dendreon sales process

30-01-2015

US biotech firm Dendreon says it has reached an agreement with Canada’s Valeant Pharmaceuticals International…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvengeValeant Pharmaceuticals International

Dendreon extends deadline for qualified bids for the company

Dendreon extends deadline for qualified bids for the company

28-01-2015

US biotech firm Dendreon said yesterday that it would be extending the bid deadline for interested parties…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvenge

Cardio3 BioSciences acquires Celdara’s OnCyte division

Cardio3 BioSciences acquires Celdara’s OnCyte division

06-01-2015

Belgian biotech firmCardio3 BioSciences has acquired OnCyte, the oncology division of privately-held…

BiotechnologyCardio3 BioSciencesCeldara MedicalMergers & AcquisitionsOncologyOnCyte

Janssen partners with MacroGenics in up to $625 million deal

Janssen partners with MacroGenics in up to $625 million deal

23-12-2014

Shares of US biotech firm MacroGenics rocketed 11.7% to a 10-month high of $38.58 yesterday, on the news…

BiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingMacroGenicsMergers & AcquisitionsMGD011Oncology

Merck & Co in up to $375 million deal to acquire OncoEthix

Merck & Co in up to $375 million deal to acquire OncoEthix

19-12-2014

US pharma giant Merck & Co said yesterday that it has acquired, through a subsidiary, Swiss-based privately…

BiotechnologyMerck & CoMergers & AcquisitionsOncoEthixOncologyOTX015

Roche to acquire Austrian next-generation antibody firm Dutalys

Roche to acquire Austrian next-generation antibody firm Dutalys

19-12-2014

Swiss pharma giant Roche has agreed to acquire Dutalys, a privately held biotechnology company based…

BiotechnologyDutalysDutaMabMergers & AcquisitionsOncologyRoche

NetScientific invests in PDS Biotechnology

NetScientific invests in PDS Biotechnology

15-12-2014

UK-based life sciences investor NetScientific has made an undisclosed investment in privately-held US…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsNetScientificOncologyPDS BiotechnologyUK

Bristol-Myers enters option deal to acquire F-star Alpha and FS102

28-10-2014

US pharma major Bristol-Myers Squibb has entered into an agreement that provides it with the exclusive…

BiotechnologyBristol-Myers SquibbF-star AlphaFS102Mergers & AcquisitionsOncology

1 to 9 of 81 results

COMPANY SPOTLIGHT

Menarini

Back to top